Bergapten

Bergapten at a Glance

Bergapten, better known as 5-methoxypsoralen (5-MOP), is a linear furanocoumarin — a coumarin fused to a furan ring, in the psoralen sub-family. It is one of the signature molecules of oil of bergamot (from which it takes its name) and occurs across the carrot and citrus families: angelica, common rue, giant hogweed, figs, celery, parsnip and expressed citrus peel oils.

Its defining property is phototoxicity. Bergapten slips flat between the base pairs of DNA and, when the skin is then exposed to ultraviolet A (UVA) light, forms covalent adducts and cross-links with DNA. This one photochemical fact runs through everything the molecule is known for: it is why bergapten-containing plant sap and citrus oils cause phytophotodermatitis on sunny skin, and it is also why 5-MOP is used deliberately, with metered UVA, in PUVA photochemotherapy for psoriasis and vitiligo.

Most of bergapten’s other reported activities — anti-inflammatory, anticancer, bone-protective — are preclinical (cell and animal studies). The molecule’s honest headline is a safety one: it is a photosensitiser and a CYP3A4 inhibitor, and its therapeutic use carries a documented photocarcinogenicity and cataract risk. Its close siblings imperatorin, angelicin and osthole are the other furanocoumarins of the same plants; psoralen and xanthotoxin (8-MOP) are its direct structural analogues.

Established Use: PUVA Photochemotherapy

Bergapten’s clearest real-world role is medical. In PUVA (Psoralen + UVA) photochemotherapy, a psoralen is given — orally, topically or in a bath — and the skin is then exposed to a controlled dose of long-wave ultraviolet A. The psoralen photosensitises the skin so that a low UVA dose halts the excessive cell division and inflammation of conditions such as psoriasis, vitiligo, mycosis fungoides and atopic eczema ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}.

Two psoralens dominate this use: xanthotoxin (8-MOP) and bergapten (5-MOP). 8-MOP is the more potent photosensitiser and the historical standard; 5-MOP is the gentler alternative, associated with less nausea and a somewhat narrower phototoxic margin, and it was developed into dedicated oral preparations for psoriasis ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}. The therapeutic effect and the hazard are the same mechanism at different doses — controlled DNA photodamage that suppresses hyperproliferation therapeutically, but which, accumulated over many sessions, raises long-term skin-cancer and cataract risk (see Toxicity & Safety) ^{6,7,8Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →Reference 7Stern RS et al. · 1997Clinical trialMalignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)View study →Reference 8Stern RS · 1998Meta-analysisRisk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysisView study →}.

Phototoxicity & DNA Cross-Linking

This is the section the molecule exists for. Bergapten is a linear (not angular) furanocoumarin, and that geometry is decisive.

In the dark, bergapten intercalates — its flat, three-ring shape slides between adjacent DNA base pairs, favouring runs of the pyrimidine base thymine ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}. Nothing damaging has happened yet. On absorbing a UVA photon (~320–400 nm), the excited molecule undergoes a [2 + 2] cycloaddition with a pyrimidine base, forming a covalent monoadduct ^{6,9Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →}. Because a linear psoralen has two photoreactive sites (the furan and the pyranone double bonds), a monoadduct on one strand can absorb a second photon and react with a pyrimidine on the opposite strand, producing an interstrand cross-link ^{6,9Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →}. Cross-links lock the double helix shut, block replication and transcription, and — if unrepaired — are cytotoxic, mutagenic and, cumulatively, carcinogenic ^{6,8,9Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →Reference 8Stern RS · 1998Meta-analysisRisk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysisView study →Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →}.

The same event is therapeutic and hazardous depending on dose and control: a dermatologist times a low UVA dose to metered skin drug levels to stop runaway proliferation; uncontrolled sun exposure after contact with bergapten-rich sap or citrus oil produces the burning, blistering and streaky brown pigmentation of phytophotodermatitis / berloque dermatitis ^{10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}. Comparative work that assigns furocoumarins phototoxic and photo-genotoxic equivalency factors ranks 5-MOP and 8-MOP among the most potent members of the class ^{9Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →}. This DNA-photochemistry is entirely distinct from the molecule’s dark (non-photoactivated) biology described below.

What It's Used For

Beyond photochemotherapy, bergapten has a broad but largely preclinical pharmacology. Reviews catalogue anti-inflammatory, anticancer, anti-osteoporotic, antimicrobial, neuroprotective and antidiabetic signals — nearly all from cell and rodent models, and some of it, importantly, independent of photoactivation ^{1Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Only the first row reflects an established human use; the rest are preclinical.

01PUVA Photochemotherapy (Psoriasis & Vitiligo)Promising56%Established dermatological use of 5-MOP + metered UVA ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}

02Anti-Inflammatory (NLRP3 / Pyroptosis)Shaky32%Macrophage & mouse models; mitophagy-driven NLRP3 suppression ^{1,4Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 4Luo T et al. · 2023Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagyView study →}

03Anticancer (Breast, p53-Dependent)Shaky24%In-vitro breast-cancer cells; apoptosis independent of photoactivation ^{3Reference 3Panno ML et al. · 2009Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cellsView study →}

04Bone / Anti-OsteoporoticShaky22%Cell + rodent osteoblast-differentiation and osteoporosis models ^{5Reference 5Xiao JJ et al. · 2015In vitroBergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivoView study →}

Mechanisms

The top row is the molecule’s identity — UVA-triggered DNA cross-linking is simultaneously its therapy, its poison and its cancer risk. The CYP3A4 row is the practical everyday hazard for anyone combining bergamot/citrus exposure with medication.

Pharmacokinetics

Bergapten is a small, lipophilic furanocoumarin. Reviews report relatively high oral bioavailability for a coumarin and note that it can cross the blood–brain barrier, which is why it is studied for CNS as well as dermatological indications ^{1Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →}. In photochemotherapy the key pharmacokinetic variable is timing: UVA is delivered to coincide with peak drug levels in skin, because the therapeutic (and phototoxic) reaction only occurs while the molecule is present and being irradiated ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}. Metabolically, bergapten is both a substrate and a mechanism-relevant inhibitor of CYP3A4; in Caco-2 / CYP3A4 systems it inhibits the enzyme with an IC₅₀ near 1 µM (less potent than bergamottin’s ~0.45 µM but in the same range), the basis of the grapefruit/bergamot furanocoumarin drug-interaction effect ^{11Reference 11Ohnishi A et al. · 2000Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4View study →}.

Clinical Trials

Human evidence is confined to dermatology: 5-MOP has a long clinical record as a PUVA agent for psoriasis and vitiligo, including dedicated oral preparations and comparisons with 8-MOP ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}. The large long-term human datasets are the PUVA follow-up cohorts that quantified skin-cancer risk ^{7,8Reference 7Stern RS et al. · 1997Clinical trialMalignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)View study →Reference 8Stern RS · 1998Meta-analysisRisk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysisView study →} — safety, not efficacy, studies. Every non-dermatological application (anti-inflammatory, anticancer, bone) sits at the preclinical stage.

Last checked: July 2026.

Isolate vs. Plant Studies

Bergapten’s human evidence is isolate evidence: PUVA uses purified 5-MOP at defined doses with metered UVA, so the dermatological record is genuinely about the molecule, not a plant extract ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}. The preclinical anti-inflammatory, anticancer and bone studies are likewise isolated-compound work in cells and rodents ^{3,4,5Reference 3Panno ML et al. · 2009Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cellsView study →Reference 4Luo T et al. · 2023Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagyView study →Reference 5Xiao JJ et al. · 2015In vitroBergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivoView study →}.

The whole-plant side of bergapten’s story is almost entirely a safety story. In nature it arrives inside complex furanocoumarin mixtures — bergamot oil, angelica, rue, giant hogweed sap, celery and parsnip — where it acts alongside xanthotoxin, psoralen, imperatorin and bergamottin, and the phototoxic burden is the sum of the mixture, not bergapten alone ^{9,10Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}. Furanocoumarin content also swings widely with species, chemotype, plant part and stress, so exposure from a plant or oil is far less predictable than a measured drug dose ^{10,12Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →Reference 12Gardana C et al. · 2008Evaluation of flavonoids and furanocoumarins from Citrus bergamia (bergamot) juice and identification of new compoundsView study →}.

Prevalence in Nature

Bergapten is one of the more widespread furanocoumarins, concentrated in two plant families: the Rutaceae (citrus, rue) and the Apiaceae (angelica, celery, parsnip, giant hogweed, plus figs in the Moraceae).

Its namesake source is oil of bergamot (Citrus bergamia); bergamot juice carries bergapten at about 9.0 mg/L, with bergamottin the other major furanocoumarin ^{12Reference 12Gardana C et al. · 2008Evaluation of flavonoids and furanocoumarins from Citrus bergamia (bergamot) juice and identification of new compoundsView study →}. It is a prominent constituent of angelica (Angelica archangelica) and common rue (Ruta graveolens), and of the notorious phototoxic sap of giant hogweed (Heracleum mantegazzianum) ^{10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}. In food-survey work, bergapten and xanthotoxin are the two most frequently detected furocoumarins in celery and parsnip: bergapten appeared in ~63% of celery and ~96% of parsnip samples, within total furocoumarin loads that reach a mean of ~1.9 µg/g in celery and up to ~145 µg/g in parsnip ^{13Reference 13Lombaert GA et al. · 2001Furanocoumarins in celery and parsnips: method and multiyear Canadian surveyView study →}. US-food quantitation confirms citrus (grapefruit, lime, bergamot) and certain umbellifers as the dietary carriers ^{2Reference 2Melough MM et al. · 2017Identification and quantitation of furocoumarins in popularly consumed foods in the U.S. using QuEChERS extraction coupled with UPLC-MS/MS analysisView study →}.

Major Natural Sources

Source	Part	Figure	Note
Bergamot (Citrus bergamia)	juice	~9.0 mg/L bergapten	namesake source; peel oil richer still 12Reference 12Gardana C et al. · 2008Evaluation of flavonoids and furanocoumarins from Citrus bergamia (bergamot) juice and identification of new compoundsView study →
Parsnip (Pastinaca sativa)	root	up to ~145 µg/g total furocoumarins; bergapten in ~96%	one of the two dominant furocoumarins 13Reference 13Lombaert GA et al. · 2001Furanocoumarins in celery and parsnips: method and multiyear Canadian surveyView study →
Celery (Apium graveolens)	stalk/root	mean ~1.9 µg/g total furocoumarins; bergapten in ~63%	rises sharply in stressed/diseased plants 13Reference 13Lombaert GA et al. · 2001Furanocoumarins in celery and parsnips: method and multiyear Canadian surveyView study →
Angelica, rue, giant hogweed	root/leaf/sap	qualitative	classic phytophotodermatitis plants 10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →
Fig (Ficus carica)	leaf/latex	qualitative	photodermatitis from leaves/sap 2Reference 2Melough MM et al. · 2017Identification and quantitation of furocoumarins in popularly consumed foods in the U.S. using QuEChERS extraction coupled with UPLC-MS/MS analysisView study →

Discovery & Synthesis

Bergapten was first isolated from oil of bergamot in the nineteenth century, and its name is a direct nod to that source — bergamot (Citrus bergamia). Its structure as a 5-methoxy-substituted linear furanocoumarin (a psoralen) was worked out later, and the photobiology that defines it — the UVA-driven cross-linking of DNA — belongs to the twentieth-century study of psoralen photochemistry that also underpinned PUVA therapy ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}.

Manufacture today is by extraction from plant sources (bergamot and other citrus, Ammi/Ruta species) and by total synthesis for pharmaceutical-grade 5-MOP; the synthetic routes build the furan ring onto a methoxy-hydroxycoumarin scaffold. Because phototoxicity is undesirable in most consumer products, the fragrance and cosmetics industries went the other way and developed “bergapten-free” (FCF) bergamot oil, from which the furanocoumarin is stripped ^{10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}.

Patents: not yet researched.

Toxicity & Safety

Bergapten carries a moderate flag. Its intrinsic (dark) acute toxicity is low, but it is a phototoxin and a photomutagen, and it is a CYP3A4 inhibitor — so its real-world hazards are (1) light-triggered skin damage and (2) drug interactions, plus the long-term cancer risk that comes with therapeutic use.

Safety at a Glance

⚠️ Moderate toxicity

• Phototoxic — the headline. Skin contact with bergapten-containing sap or citrus oil, followed by UVA/sun, causes phytophotodermatitis (berloque dermatitis): burning, blistering and lingering brown streaks.
• Photocarcinogenicity & cataract risk in PUVA. Repeated therapeutic 5-MOP + UVA raises squamous-cell carcinoma, melanoma and cataract risk dose-dependently over years — PUVA is medically supervised for this reason.
• CYP3A4 inhibition (the citrus/bergamot effect). Bergapten inhibits CYP3A4, so bergamot/grapefruit-type furanocoumarin exposure can raise blood levels of many medications.
• Low intrinsic toxicity without light. Absent UVA, bergapten’s acute oral toxicity is low; the danger is contingent on ultraviolet exposure.

Full Safety & Interactions Detail

Phytophotodermatitis / berloque dermatitis. The classic hazard: bergapten from expressed citrus (lime, bergamot, lemon) peel oils, or from the sap of rue, angelica, giant hogweed, wild parsnip and celery, deposits on skin; subsequent sun/UVA triggers a phototoxic burn with characteristic streaky hyperpigmentation. It is a reaction of the whole furanocoumarin mixture, with bergapten and xanthotoxin among the main actors ^{9,10Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}. Historically, bergapten-containing bergamot oil in perfumes and suntan preparations caused widespread berloque dermatitis, which is why cosmetics moved to bergapten-free oil and regulators capped furanocoumarin levels in leave-on, sun-exposed products ^{10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}.

Photocarcinogenicity and cataract (therapeutic exposure). Because the therapeutic mechanism is DNA photodamage, long-term PUVA carries an oncogenic cost. Large follow-up cohorts of psoralen + UVA-treated psoriasis patients found a dose-dependent increase in squamous-cell carcinoma ^{8Reference 8Stern RS · 1998Meta-analysisRisk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysisView study →} and an increased malignant-melanoma risk that rose with cumulative treatments and emerged years after therapy ^{7Reference 7Stern RS et al. · 1997Clinical trialMalignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)View study →}. UVA also promotes cataract, an effect enhanced by psoralens — hence the eye protection required after dosing. These risks are established for the psoralen/PUVA class (chiefly 8-MOP, with 5-MOP a member of the same class) ^{7,8,9Reference 7Stern RS et al. · 1997Clinical trialMalignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)View study →Reference 8Stern RS · 1998Meta-analysisRisk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysisView study →Reference 9Raquet N · 2014Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixturesView study →}.

Drug interactions (CYP3A4). Bergapten is one of the citrus/bergamot furanocoumarins that inhibit intestinal and hepatic CYP3A4 (IC₅₀ ≈ 1 µM in Caco-2/CYP3A4 systems), the enzyme that metabolises a large share of oral drugs ^{11Reference 11Ohnishi A et al. · 2000Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4View study →}. Like the grapefruit-juice effect, meaningful bergamot/furanocoumarin exposure can raise plasma levels of CYP3A4 substrates (some statins, calcium-channel blockers, immunosuppressants and others), increasing effect and toxicity. This interaction is a property of the plant/oil furanocoumarin content, not only of isolated drug 5-MOP.

Reproductive / developmental note (prose only). Furanocoumarins are genotoxic under UVA, and psoralen photochemotherapy is generally avoided in pregnancy at the drug level; no clean isolate reproductive-toxicity dataset is characterised here for bergapten specifically. Pregnancy and lactation decisions belong to the herb or product page where intake is decided, not to this molecule page. Never infer safety from silence — the phototoxic and photogenotoxic findings above are the load-bearing cautions.

Dosage

There is no general dietary or supplemental dose for bergapten — everyday exposure is incidental, from bergamot and other citrus foods and oils, aromatherapy preparations, and umbellifer vegetables (celery, parsnip) and herbs (angelica, rue). The only defined human dosing is medical, as 5-MOP in PUVA, where a dermatologist matches an oral dose (historically around 1.2 mg/kg), or a topical/bath preparation, to a controlled UVA dose and enforces eye and skin protection afterward ^{1,6Reference 1Liang Y et al. · 2021ReviewBergapten: a review of its pharmacology, pharmacokinetics, and toxicityView study →Reference 6Irizar A et al. · 2025ReviewPhototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extractsView study →}.

For consumer safety the relevant “dose” is a ceiling, not a target: fragrance and cosmetic standards limit or remove bergapten (bergapten-free bergamot oil) in products meant for sun-exposed skin because of phototoxicity ^{10Reference 10Knapp CF 3rd · 2009Botanical briefs: garden Angelica (Angelica archangelica)View study →}. These are medical and regulatory figures, not a personal recommendation.

References

1. Liang Y, Xie L, et al. (2021). Bergapten: a review of its pharmacology, pharmacokinetics, and toxicity. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/34347307/
2. Melough MM, et al. (2017). Identification and quantitation of furocoumarins in popularly consumed foods in the U.S. using QuEChERS extraction coupled with UPLC-MS/MS analysis. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/28581738/
3. Panno ML, et al. (2009). Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells. Current Cancer Drug Targets. https://pubmed.ncbi.nlm.nih.gov/19519316/
4. Luo T, et al. (2023). Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy. Acta Pharmacologica Sinica. https://pubmed.ncbi.nlm.nih.gov/37142684/
5. Xiao JJ, et al. (2015). Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo. Molecular and Cellular Biochemistry. https://pubmed.ncbi.nlm.nih.gov/26188800/
6. Irizar A, et al. (2025). Phototoxicity and skin damage: a review of adverse effects of some furocoumarins found in natural extracts. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/39984024/
7. Stern RS, Nichols KT, Väkevä LH (1997). Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/9091799/
8. Stern RS, Lunder EJ (1998). Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysis. Archives of Dermatology. https://pubmed.ncbi.nlm.nih.gov/9875197/
9. Raquet N, Schrenk D (2014). Application of the equivalency factor concept to the phototoxicity and -genotoxicity of furocoumarin mixtures. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/24680798/
10. Knapp CF 3rd, Elston DM (2009). Botanical briefs: garden Angelica (Angelica archangelica). Cutis. https://pubmed.ncbi.nlm.nih.gov/19911672/
11. Ohnishi A, et al. (2000). Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. British Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/10903978/
12. Gardana C, et al. (2008). Evaluation of flavonoids and furanocoumarins from Citrus bergamia (bergamot) juice and identification of new compounds. Molecules. https://pubmed.ncbi.nlm.nih.gov/18830151/
13. Lombaert GA, et al. (2001). Furanocoumarins in celery and parsnips: method and multiyear Canadian survey. Journal of AOAC International. https://pubmed.ncbi.nlm.nih.gov/11501915/

View all 13 references▾